Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
24.38
-0.21 (-0.85%)
At close: Jun 12, 2026, 4:00 PM EDT
23.91
-0.47 (-1.91%)
After-hours: Jun 12, 2026, 7:40 PM EDT
Arcutis Biotherapeutics Market Cap
Arcutis Biotherapeutics has a market cap or net worth of $3.05 billion as of June 12, 2026. Its market cap has increased by 87.15% in one year.
Market Cap
3.05B
Enterprise Value
2.94B
1-Year Change
87.15%
Ranking
Category
Stock Price
$24.38
Market Cap Chart
Since January 31, 2020, Arcutis Biotherapeutics's market cap has increased from $782.04M to $3.05B, an increase of 289.95%. That is a compound annual growth rate of 23.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 3.05B | -14.27% |
| Dec 31, 2025 | 3.56B | 118.17% |
| Dec 31, 2024 | 1.63B | 434.82% |
| Dec 29, 2023 | 304.85M | -66.18% |
| Dec 30, 2022 | 901.45M | -13.58% |
| Dec 31, 2021 | 1.04B | -14.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Denali Therapeutics | 3.44B |
| Viking Therapeutics | 3.34B |
| Telix Pharmaceuticals | 3.26B |
| Relay Therapeutics | 3.23B |
| Alumis | 3.08B |
| Structure Therapeutics | 3.05B |
| Dyne Therapeutics | 3.01B |
| Arcus Biosciences | 2.99B |